These results are consistent with another work in which targeting TNFα to the tumor vasculature also increased the therapeutic efficacy of immune checkpoint blockade as well as adoptive cell therapy by enhancing T-cell infiltration [48]. The gene discussed is TNF; the disease is neoplasm.